650 related articles for article (PubMed ID: 28536452)
1. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.
von Karstedt S; Montinaro A; Walczak H
Nat Rev Cancer; 2017 May; 17(6):352-366. PubMed ID: 28536452
[TBL] [Abstract][Full Text] [Related]
2. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
[TBL] [Abstract][Full Text] [Related]
3. TRAIL signalling: decisions between life and death.
Falschlehner C; Emmerich CH; Gerlach B; Walczak H
Int J Biochem Cell Biol; 2007; 39(7-8):1462-75. PubMed ID: 17403612
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.
Woo SM; Kwon TK
BMB Rep; 2019 Feb; 52(2):119-126. PubMed ID: 30638181
[TBL] [Abstract][Full Text] [Related]
5. The clinical trail of TRAIL.
Duiker EW; Mom CH; de Jong S; Willemse PH; Gietema JA; van der Zee AG; de Vries EG
Eur J Cancer; 2006 Sep; 42(14):2233-40. PubMed ID: 16884904
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling.
Thorburn A
J Thorac Oncol; 2007 Jun; 2(6):461-5. PubMed ID: 17545839
[TBL] [Abstract][Full Text] [Related]
7. Targeting TRAIL towards the clinic.
Mahalingam D; Oldenhuis CN; Szegezdi E; Giles FJ; de Vries EG; de Jong S; Nawrocki ST
Curr Drug Targets; 2011 Dec; 12(14):2079-90. PubMed ID: 21777191
[TBL] [Abstract][Full Text] [Related]
8. TRAIL death receptors and cancer therapeutics.
Huang Y; Sheikh MS
Toxicol Appl Pharmacol; 2007 Nov; 224(3):284-9. PubMed ID: 17240413
[TBL] [Abstract][Full Text] [Related]
9. Developing TRAIL/TRAIL death receptor-based cancer therapies.
Yuan X; Gajan A; Chu Q; Xiong H; Wu K; Wu GS
Cancer Metastasis Rev; 2018 Dec; 37(4):733-748. PubMed ID: 29541897
[TBL] [Abstract][Full Text] [Related]
10. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.
Dai X; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Exp Biol Med (Maywood); 2015 Jun; 240(6):760-73. PubMed ID: 25854879
[TBL] [Abstract][Full Text] [Related]
11. Targeting TRAIL agonistic receptors for cancer therapy.
Carlo-Stella C; Lavazza C; Locatelli A; Viganò L; Gianni AM; Gianni L
Clin Cancer Res; 2007 Apr; 13(8):2313-7. PubMed ID: 17438088
[TBL] [Abstract][Full Text] [Related]
12. From biochemical principles of apoptosis induction by TRAIL to application in tumour therapy.
Cordier SM; Papenfuss K; Walczak H
Results Probl Cell Differ; 2009; 49():115-43. PubMed ID: 19142621
[TBL] [Abstract][Full Text] [Related]
13. TRAIL and other TRAIL receptor agonists as novel cancer therapeutics.
Falschlehner C; Ganten TM; Koschny R; Schaefer U; Walczak H
Adv Exp Med Biol; 2009; 647():195-206. PubMed ID: 19760076
[TBL] [Abstract][Full Text] [Related]
14. The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS).
Mellier G; Pervaiz S
Free Radic Res; 2012 Aug; 46(8):996-1003. PubMed ID: 22559302
[TBL] [Abstract][Full Text] [Related]
15. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A; Micheau O
Cells; 2024 Mar; 13(6):. PubMed ID: 38534365
[TBL] [Abstract][Full Text] [Related]
16. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
[TBL] [Abstract][Full Text] [Related]
17. Clinical perspectives of TRAIL: insights into central nervous system disorders.
Tisato V; Gonelli A; Voltan R; Secchiero P; Zauli G
Cell Mol Life Sci; 2016 May; 73(10):2017-27. PubMed ID: 26910728
[TBL] [Abstract][Full Text] [Related]
18. Death receptor 5 is activated by fucosylation in colon cancer cells.
Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
[TBL] [Abstract][Full Text] [Related]
19. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
Secchiero P; Zauli G
Curr Opin Hematol; 2008 Jan; 15(1):42-8. PubMed ID: 18043245
[TBL] [Abstract][Full Text] [Related]
20. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
